ArticleInternational journal of clinical oncology2013

Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.

Aina He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.